Mohamed Mohamed-Abdallah Z, Esteban Fuertes M, Hermida Gutiérrez J, Chicharro Almarza G J, Luengo Alpuente S, Ramírez Fernández J C, Resel Estévez L
Cátedra y Servicio de Urología, Hospital Universitario San Carlos, Universidad Complutense de Madrid.
Actas Urol Esp. 1994 May;18 Suppl:465-7.
Herein it is described the survival rate, the quality of life and the complications of the upper urinary tract diversion in 22 pluri-treated tumoral patients (both male and female, average 65.2 years old). Cancer etiology has been: colon-rectum neoplasia (36.3%), bladder carcinoma (36.3%), prostate carcinoma (9.9%), ovary cancer (4.5%), abdominal wall desmoid tumor (4.5%), pheochromocytoma (4.5%) and gastric carcinoma (4.5%). Urinary diversions type has been: percutaneous nephrostomy (40.9%), ureteral stent (31.8%), both (13.6%) and cutaneous ureterostomy (13.6%). Urinary diversions were performed unilateral in 90.9%. The average survival has been 4.8 months. The quality of life was poor in 68.1%. The following complications were observed: urinary infection (45.4%), hematuria (36.3%), diversion catheter lose (34.8%) and obstruction (27.2%). Urinary diversion in pluri-treated cancer patients must be carefully indicated to prevent negative aspects upon psychophysic and social activity of the patients.
本文描述了22例接受多种治疗的肿瘤患者（男女皆有，平均年龄65.2岁）上尿路改道的生存率、生活质量和并发症情况。癌症病因包括：结直肠癌（36.3%）、膀胱癌（36.3%）、前列腺癌（9.9%）、卵巢癌（4.5%）、腹壁硬纤维瘤（4.5%）、嗜铬细胞瘤（4.5%）和胃癌（4.5%）。尿路改道类型包括：经皮肾造瘘术（40.9%）、输尿管支架置入术（31.8%）、两者皆用（13.6%）和皮肤输尿管造口术（13.6%）。90.9%的尿路改道为单侧进行。平均生存期为4.8个月。68.1%的患者生活质量较差。观察到以下并发症：尿路感染（45.4%）、血尿（36.3%）、改道导管丢失（34.8%）和梗阻（27.2%）。对于接受多种治疗的癌症患者，必须谨慎考虑尿路改道，以防止对患者的心理生理和社会活动产生负面影响。
